SuperworthSenti Biosciences shares outstanding SNTI
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 31.1M
- On a year earlier
- +19.4%
- more shares
Senti Biosciences had 31.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 19.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 27.4M | +487% |
| FY2024 | 4.7M | +4% |
| FY2023 | 4.5M | +2% |
| FY2022 | 4.4M | +1382% |
| FY2021 | 295.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 31.1M | +19% | |
| Q1 FY26 | 31M | +209% | |
| Q4 FY25 | 27.4M | +487% | |
| Q3 FY25 | 26.2M | +473% | |
| Q2 FY25 | 26.1M | +470% | |
| Q1 FY25 | 10M | +119% | |
| Q4 FY24 | 4.7M | +4% | |
| Q3 FY24 | 4.6M | +3% | |
| Q2 FY24 | 4.6M | +3% | |
| Q1 FY24 | 4.6M | +4% | |
| Q4 FY23 | 4.5M | +2% | |
| Q3 FY23 | 4.4M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Senti Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.